MedPath
HSA Approval

TRIMAXAZOLE TABLETS

SIN00407P

TRIMAXAZOLE TABLETS

TRIMAXAZOLE TABLETS

April 27, 1988

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBEACONS PHARMACEUTICALS PTE. LTD.
Licence HolderBEACONS PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

J01EE01

sulfamethoxazole and trimethoprim

Manufacturer Information

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Active Ingredients

SULPHAMETHOXAZOLE

400 mg

Sulfamethoxazole

TRIMETHOPRIM

80 mg

Trimethoprim

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TRIMAXAZOLE TABLETS - HSA Approval | MedPath